Literature DB >> 15655149

Definitions of measures of effect duration for psoriasis treatments.

Kenneth B Gordon, Steven R Feldman, John Y M Koo, Alan Menter, Tara Rolstad, Gerald Krueger.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15655149     DOI： 10.1001/archderm.141.1.82

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  11 in total

1.  How Long Does the Benefit of Biologics Last? An Update on Time To Relapse and Potential for Rebound of Biologic Agents for Psoriasis.

Authors:  Monique Kamaria; Wilson Liao; J Y Koo
Journal:  Psoriasis Forum       Date:  2010

2.  Post-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCs.

Authors:  Leanne M Johnson-Huang; Cara A Pensabene; Kejal R Shah; Katherine C Pierson; Toyoko Kikuchi; Tim Lentini; Patricia Gilleaudeau; Mary Sullivan-Whalen; Inna Cueto; Artemis Khatcherian; Luke A Hyder; Mayte Suárez-Fariñas; James G Krueger; Michelle A Lowes
Journal:  PLoS One       Date:  2012-02-10       Impact factor: 3.240

3.  Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence.

Authors:  Kim A Papp; Darryl Toth; Les Rosoph
Journal:  BMC Dermatol       Date:  2006-10-26

4.  Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.

Authors:  Dan-Ni Yao; Chuan-Jian Lu; Ze-Huai Wen; Yu-Hong Yan; Mei-Ling Xuan; Xiao-Yan Li; Geng Li; Ze-Hui He; Xiu-Li Xie; Jing-Wen Deng; Xin-Feng Guo; Ai-Hua Ou
Journal:  Trials       Date:  2016-03-16       Impact factor: 2.279

5.  Auricular acupressure as a complementary therapy for psoriasis vulgaris: study protocol for a multicenter randomized controlled trial.

Authors:  Jingwen Deng; Chuanjian Lu; Yu Xiang; Hao Deng; Zehuai Wen; Danni Yao; Meiling Xuan; Yuhong Yan
Journal:  Trials       Date:  2019-06-17       Impact factor: 2.279

6.  Fire needle acupuncture or moxibustion for chronic plaque psoriasis: study protocol for a randomized controlled trial.

Authors:  Zhaoxia Chen; Dongmei Zhou; Yan Wang; Haibing Lan; Xingwu Duan; Bohua Li; Jingxia Zhao; Wei Li; Zhengrong Liu; Tingting Di; Xinwei Guo; Jinchao Zhang; Bo Li; Shuo Feng; Ping Li
Journal:  Trials       Date:  2019-12-04       Impact factor: 2.279

7.  Efalizumab in the treatment of psoriasis.

Authors:  Wolf-Henning Boehncke
Journal:  Biologics       Date:  2007-09

8.  Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized controlled trial.

Authors:  Ze-Huai Wen; Mei-Ling Xuan; Yu-Hong Yan; Xiao-Yan Li; Dan-Ni Yao; Geng Li; Xin-Feng Guo; Ai-Hua Ou; Chuan-Jian Lu
Journal:  Trials       Date:  2014-07-22       Impact factor: 2.279

9.  A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.

Authors:  Liming Lu; Meiling Xuan; Yuhong Yan; Geng Li; Li Zhou; Zehuai Wen; Chuanjian Lu
Journal:  Trials       Date:  2016-10-03       Impact factor: 2.279

10.  Traditional Chinese medicine for psoriasis vulgaris: A Protocol of a prospective, multicenter cohort study.

Authors:  Xinwei Guo; Dongmei Zhou; Liyun Sun; Ping Wang; Jianhua Qu; Cang Zhang; Yan Wang; Zhaoxia Chen; Bo Li; Jing Hu; Zhimiao Lin; Fei Shi; Yanping Bai; Yuanwen Li; Xingwu Duan; Shentao Bao; Haibing Lan; Xiaoyan Sun; Xiong Wang; Xiang Liu; Linge Li; Litao Zhang; Fang Feng; Yujiao Meng; Qingwu Liu; Xiaoyao Guo; Jianning Guo; Yu Liu; Cong Qi; Jia Chen; Shuo Feng; Ping Li
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.